MAGGIER QUINOA: Open Payments
NPI 1326581943 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 18 payments from 7 companies in 2025. Trend: 2023 $200 · 2024 $61 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $191 |
| Daiichi Sankyo Inc. | 2 | $59 |
| AstraZeneca Pharmaceuticals LP | 1 | $29 |
| Astellas Pharma US Inc | 1 | $28 |
| Janssen Biotech, Inc. | 1 | $26 |
| Caris MPI, Inc. | 1 | $21 |
| BeOne Medicines USA, Inc. | 1 | $17 |
Products named: JEMPERLI, Enhertu, DATROWAY, Veozah, DARZALEX, MI CANCER SEEK, TEVIMBRA.
Industry payments across FL — which companies pay providers there.
